Roche sales slide as COVID boost fades away
Roche's quarterly sales declined 6% as a slump in COVID treatments and diagnostic testing outweighed gains from hemophilia and multiple sclerosis treatments.
Suscribirse a:
Enviar comentarios (Atom)
Comentarios
Publicar un comentario
Leave a comment. Thanks!
Comentarios de Facebook